Devon Medical today launched its portable extriCARE 2400 Negative Pressure Wound Therapy system at the European Wound Management Association conference is Copenhagen, Denmark, after it won CE Mark approval in the European Union.
"The extriCARE system has proven itself in the U.S. as a powerful device that healthcare professionals can rely on for the management of non-healing wounds, including diabetic ulcers and chronic, acute, traumatic, subacute, and dehisced wounds," Devon Medical founder and CEO Dr. John Bennett said in a press statement.
"The device’s portability allows patients to receive wound healing treatment inside of their own home while participating in normal daily activities," he continued. "We are excited to receive the CE mark as it will allow us to work with healthcare professionals to achieve similar patient compliance and positive outcomes across Europe and other parts of the world."
Negative pressure wound therapy has traditionally been used in facility settings, including hospitals, nursing homes, and long term care facilities, Devon Medical pointed out.
The extriCARE system comprises the extriCARE 2400 pump, which weighs less than 1 pound, and Devon Medical’s anatomically fitted negative pressure wound therapy dressings, the King Of Prussia, Pa., headquartered company stated in a press release.
A dressing is applied to a wound to create a tight seal, and the pump’s pressure creates a negative pressure or vacuum environment that draws blood to the wound bed, the company explained. The process also removes exudates into a disposable canister located on the back of the pump.